OCTAVE SPECIALTY GROUP INC annual report, FY2018

Business Context and Reporting Period

The source filing identifies Ambac Financial Group, Inc., not Octave Specialty Group Inc. This Form 10-K covers the fiscal year ended December 31, 2018, including fourth-quarter results. Ambac is a financial-services holding company whose principal financial-guarantee insurance subsidiaries have been in runoff since 2008 and cannot write new business. The company operates as one consolidated reportable segment.

On February 12, 2018, Ambac completed the Rehabilitation Exit Transactions and concluded rehabilitation of the Segregated Account. Management’s strategy remains focused on runoff, risk reduction, litigation recoveries, liability management, investment returns and selective evaluation of adjacent new businesses.

Financial Performance and Key Metrics

Metric	2018	2017	Change
Total revenues	$510.7 million	$622.2 million	Down $111.5 million
Net premiums earned	$111.1 million	$175.3 million	Down 36.6%
Net investment income	$272.7 million	$361.0 million	Down $88.2 million
Net realized investment gains	$111.6 million	$5.4 million	Higher by $106.3 million
Losses and loss expenses	Benefit of $223.6 million	Expense of $513.2 million	Improved by $736.8 million
Pre-tax income	$272.5 million	Loss of $284.3 million	Improved by $556.8 million
Net income attributable to common stockholders	$185.7 million	Loss of $328.7 million	Improved by $514.4 million
Diluted earnings per share	$3.99	$(7.25)	Improved
Total comprehensive income attributable to common stockholders	$192.1 million	Loss of $335.4 million	Improved by $527.5 million

Approximate consolidated pre-tax margin was 53.4% and net income attributable to common stockholders represented approximately 36.4% of total revenues. These percentages were significantly affected by the rehabilitation-related benefit, investment gains and other unusual items and are not representative of recurring operating margins.

Fourth-quarter 2018 net income attributable to common stockholders was a loss of $20.5 million, compared with a loss of $19.5 million in fourth-quarter 2017. Fourth-quarter 2018 pre-tax loss was $22.1 million.
Operating expenses declined to $112.2 million from $122.4 million, while interest expense increased to $242.3 million from $119.9 million following the issuance of the Ambac Note and Tier 2 Notes.
Insurance intangible amortization declined to $107.3 million from $150.9 million.
Cash used in operating activities was $1.543 billion, compared with $221.3 million in 2017, primarily reflecting the $1.354 billion cash outflow associated with the Rehabilitation Exit Transactions.
Investing activities provided $1.588 billion, while financing activities used $585.4 million. Net cash flow was negative $541.2 million.
Cash, cash equivalents and restricted cash totaled $83.5 million at year-end, including $63.1 million of unrestricted cash and $19.4 million of restricted cash.
Consolidated non-VIE investments totaled $3.937 billion, down from $5.741 billion. Parent-company cash, investments and receivables totaled approximately $455 million.
Total assets were $14.589 billion and total liabilities were $12.956 billion. Total stockholders’ equity was $1.633 billion, compared with $1.645 billion at December 31, 2017.

Debt, Liquidity and Capital

Long-term debt increased to $2.929 billion from $991.7 million, primarily because of the $1.940 billion Ambac Note and $251.7 million of Tier 2 Notes issued in connection with the rehabilitation exit transactions. The secured borrowing was fully repaid in June 2018.
Ambac Assurance had approximately $2.199 billion of senior indebtedness consisting of the Ambac Note and Tier 2 Notes, plus $573.8 million of senior surplus-note principal and $366.6 million of junior surplus-note principal at year-end.
The Ambac Note had a February 2023 legal maturity, bears interest at three-month U.S. dollar LIBOR plus 5.00% subject to a 1.00% floor, and was reduced by $214.1 million during 2018.
The Tier 2 Notes mature in February 2055, bear 8.50% interest that generally compounds as paid-in-kind interest, and are secured by specified RMBS litigation recoveries above $1.6 billion.
Ambac Assurance’s statutory policyholder surplus increased to $1.152 billion from $699.6 million. Qualified statutory capital was $1.648 billion, compared with $1.156 billion.
Ambac UK remained deficient under Solvency II: eligible capital resources were £110.2 million versus regulatory capital requirements of £357.4 million, a deficiency of £247.2 million.
Ambac Assurance has not paid common dividends to Ambac since 2008 and is not expected to pay dividends in the foreseeable future. Parent liquidity therefore depends primarily on existing cash and investments, cost reimbursements and potential tax-sharing payments, many of which require regulatory approval.
Scheduled contractual obligations totaled $15.262 billion, including $3.827 billion of surplus-note obligations, $2.563 billion of Ambac Note obligations, $5.394 billion of Tier 2 Note obligations and $3.448 billion of expected loss and loss-expense payments. Timing and amounts may vary materially.

Material Changes Versus the Prior Comparable Period

The rehabilitation exit transactions produced a $288 million loss-and-loss-expense benefit, discharged approximately $3.857 billion of Deferred Amounts and canceled approximately $809.5 million of surplus-note principal and accrued interest.
The transactions reduced cash and invested assets by approximately $1.801 billion and increased long-term debt by approximately $1.748 billion.
An August 2018 AMPS exchange repurchased 84.4% of Ambac Assurance’s auction-market preferred shares, reduced the AMPS liquidation preference from $660.3 million to $102.9 million and reduced consolidated equity by approximately $296.6 million, including an $81.7 million charge to common-stockholders’ income.
Net guaranteed par outstanding declined 25% to $46.927 billion from $62.716 billion. Public finance exposure was $23.442 billion, structured finance $9.947 billion and international finance $13.538 billion.
Adversely classified net par declined 23% to $10.9 billion and watch-list net par declined 19% to $9.0 billion.
Ambac deconsolidated four VIEs, reducing consolidated assets by approximately $6.620 billion and liabilities by approximately $6.600 billion.
During 2018, Ambac reduced exposure through commutations, calls, refundings, reinsurance and restructurings, including $484 million of commuted net par and approximately $1.5 billion of performing public-finance exposure ceded through quota-share reinsurance.

Guidance, Outlook, Risks and Unusual Items

The filing does not provide formal earnings or revenue guidance. Management expects the insurance portfolio to continue running off and intends to pursue additional commutations, restructurings, reinsurance, litigation recoveries and investment-portfolio actions. It is also evaluating selective opportunities in credit, insurance, asset management and other financial services, but provides no assurance that a transaction will be identified, financed or completed.

Puerto Rico: Ambac reported approximately $1.9 billion of net par exposure and $9.3 billion of net insured lifetime debt service to Puerto Rico and its instrumentalities at December 31, 2018. Claims, restructurings, litigation and recoveries remain highly uncertain.
COFINA: The COFINA Plan of Adjustment became effective on February 12, 2019 and reduced Ambac’s COFINA net par exposure by approximately $603 million, to approximately $202 million. Appeals remain pending, and the ultimate impact on other Puerto Rico exposures is unclear.
Loss-reserve sensitivity: Management estimated that adverse public-finance developments could increase reserves by approximately $1.0 billion. The filing also identifies possible increases of approximately $30 million for certain RMBS exposures, $25 million for student loans and $170 million for other credits, while noting that actual losses could exceed these amounts.
RMBS recoveries: The company recorded approximately $1.744 billion of net RMBS representation-and-warranty recoveries. If these recoveries were not realized, stockholders’ equity at December 31, 2018 would decrease from $1.633 billion to approximately negative $111.1 million.
Regulatory restrictions: OCI approval is required for various payments and corporate actions. Ambac Assurance was in compliance with applicable aggregate risk limits but not applicable single-risk limits in New York.
Brexit: Ambac UK had six EU-passported policies with aggregate par value of approximately $2.4 billion, premium receivables of $61 million and loss reserves of $271 million. A no-deal Brexit could affect its ability to collect premiums, pay claims and retain control rights.
Litigation and contingencies: Material RMBS, Puerto Rico, student-loan servicing and other proceedings remain unresolved. The filing states that unfavorable outcomes could materially affect liquidity, capital, earnings and recoveries.
Market risk: A 100-basis-point rise in interest rates was estimated to increase net fair value by $91 million for the relevant portfolio, while a 250-basis-point widening in credit spreads was estimated to reduce investment fair value by $104 million.
Tax assets: Ambac had approximately $3.5 billion of U.S. federal net operating-loss carryforwards but maintained a full valuation allowance against the related domestic deferred-tax assets.

Most Important Facts for Investors to Verify

Confirm that the filing belongs to Ambac Financial Group, Inc.; the supplied metadata names a different company.
Reconcile reported 2018 profitability to the $288 million rehabilitation-exit benefit, the AMPS exchange charge, investment gains and other non-recurring items.
Assess the collectability, timing and legal status of the $1.744 billion net RMBS recoveries and their role as collateral for the Ambac Note and Tier 2 Notes.
Review Puerto Rico restructuring outcomes, appeals, future claims and whether reserves adequately reflect potential losses.
Evaluate parent-company liquidity without dividends from Ambac Assurance and determine whether OCI will approve tolling payments and expense reimbursements.
Review Ambac UK’s Solvency II capital deficit and the regulatory response, including Brexit-related effects.
Analyze debt-service capacity, LIBOR exposure, mandatory redemption provisions and the priority of surplus notes, Tier 2 Notes and policyholder claims.
Compare GAAP stockholders’ equity of $1.633 billion with adjusted book value of $1.251 billion and understand the effects of insurance-intangible and unearned-premium adjustments.